myBGI
Change region
Toggle navigation

BGI Solutions for the Fight Against COVID-19

BGI has been involved in COVID-19 response efforts from the beginning of the outbreak. This direct experience, as well as our long history as one of the world’s leading genomics companies, positions us well to assist researchers understand further the molecular structure of SARS-CoV-2 and pathogenesis of the disease COVID-19. Please review some example research questions and our solutions below.

Free On-Demand Webinar

Register for and view on-demand our webinar introducing SARS-CoV-2 with a live demonstration of the system.

 

Register here, it's quick and easy.

Technical Strategy

  • Genetic susceptibility analysis
  • Immune repertoire/nanoproteomics
  • Omics data monitoring
  • Virus titer evaluation in the blood/feces

 

BGI Solutions and Services

Technical Strategy

  • Bulk immune repertoire/nanoproteomics
  • Omics data monitoring
  • Gut microbiome analysis
  • Longitudinal study

 
BGI Solutions and Services

Technical Strategy

  • Host genomics affecting drug metabolism
  • Gut microbe-drug interaction

 
BGI Solutions and Services

Technical Strategy

  • Cell-line based drug screening
  • Animal model based drug screening
  • Omics data monitoring
  • Immune repertoire/nanoproteomics

 
BGI Solutions and Services

Technical Strategy

  • Omics data monitoring
  • Immune repertoire/nanoproteomics

 
BGI Solutions and Services

Technical Strategy

  • Population genetics analysis
  • Variable region tracking
  • Evolution of the functional elements

 
BGI Solutions and Services

Technical Strategy

  • Codon optimization
  • Site-Directed Mutagenesis

 
BGI Solutions and Services

  • Positive plasmid for SARS-CoV-2 diagnosis
  • Customized probe/primer design
  • Customized gene synthesis
  • Customized codon optimization
  • Site-directed mutagenesis services, PCR cloning and subcloning services
Contact us
Quick Contact